Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002753269 | SCV003740334 | uncertain significance | Inborn genetic diseases | 2025-02-22 | criteria provided, single submitter | clinical testing | The c.985A>G (p.K329E) alteration is located in exon 4 (coding exon 4) of the TTI2 gene. This alteration results from a A to G substitution at nucleotide position 985, causing the lysine (K) at amino acid position 329 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |